2272 related articles for article (PubMed ID: 23541338)
1. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
2. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
3. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
4. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.
Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E
Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519
[TBL] [Abstract][Full Text] [Related]
5. Management of Benign Prostatic Hyperplasia in Older Adults.
Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
[TBL] [Abstract][Full Text] [Related]
6. Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.
Marberger M
Adv Ther; 2013 Apr; 30(4):309-19. PubMed ID: 23584673
[TBL] [Abstract][Full Text] [Related]
7. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
8. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.
Liatsikos E; Kyriazis I; Kallidonis P; Stolzenburg JU
Aging Male; 2011 Sep; 14(3):141-9. PubMed ID: 21247241
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms.
Füllhase C; Chapple C; Cornu JN; De Nunzio C; Gratzke C; Kaplan SA; Marberger M; Montorsi F; Novara G; Oelke M; Porst H; Roehrborn C; Stief C; McVary KT
Eur Urol; 2013 Aug; 64(2):228-43. PubMed ID: 23375241
[TBL] [Abstract][Full Text] [Related]
10. New strategies in treating male lower urinary tract symptoms.
Füllhase C; Soler R; Gratzke C
Curr Opin Urol; 2014 Jan; 24(1):29-35. PubMed ID: 24285261
[TBL] [Abstract][Full Text] [Related]
11. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
Yamaguchi O
Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
[TBL] [Abstract][Full Text] [Related]
12. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
14. Treatment of benign prostatic hyperplasia.
Pinheiro LC; Martins Pisco J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
[TBL] [Abstract][Full Text] [Related]
15. Tadalafil - a therapeutic option in the management of BPH-LUTS.
Carson CC; Rosenberg M; Kissel J; Wong DG
Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
[TBL] [Abstract][Full Text] [Related]
16. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
17. Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
Capitanio U; Salonia A; Briganti A; Montorsi F
Int J Clin Pract; 2013 Jun; 67(6):544-51. PubMed ID: 23409749
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
Schauer I; Madersbacher S
Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
[TBL] [Abstract][Full Text] [Related]
19. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
20. Current pharmacological treatment options for male lower urinary tract symptoms.
Strittmatter F; Gratzke C; Stief CG; Hedlund P
Expert Opin Pharmacother; 2013 Jun; 14(8):1043-54. PubMed ID: 23641819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
